Literature DB >> 26908999

Tiotropium Bromide/Olodaterol (Stiolto Respimat): Once-Daily Combination Therapy for the Maintenance of COPD.

Juan F Mosley, Lillian L Smith, Brittany N Dutton.   

Abstract

Tiotropium bromide/olodaterol (Stiolto Respimat): once-daily combination therapy for the maintenance of COPD.

Entities:  

Keywords:  COPD; Stiolto Respimat; anti-cholinergic; beta2 agonist; olodaterol; tiotropium bromide

Year:  2016        PMID： 26908999      PMCID： PMC4745636     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  3 in total

Review 1.  [Hospital treatment of chronic obstructive pulmonary disease exacerbations: an evidence-based review].

Authors:  M Carrera; E Sala; B G Cosío; A G N Agustí
Journal:  Arch Bronconeumol       Date:  2005-04       Impact factor: 4.872

Review 2.  Chronic obstructive pulmonary disease * 12: New treatments for COPD.

Authors:  P J Barnes
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

3.  Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).

Authors:  Roland Buhl; François Maltais; Roger Abrahams; Leif Bjermer; Eric Derom; Gary Ferguson; Matjaž Fležar; Jacques Hébert; Lorcan McGarvey; Emilio Pizzichini; Jim Reid; Antony Veale; Lars Grönke; Alan Hamilton; Lawrence Korducki; Kay Tetzlaff; Stella Waitere-Wijker; Henrik Watz; Eric Bateman
Journal:  Eur Respir J       Date:  2015-01-08       Impact factor: 16.671
  3 in total
  2 in total

Review 1.  Efficacy of tiotropium-olodaterol fixed-dose combination in COPD.

Authors:  Eric Derom; Guy G Brusselle; Guy F Joos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-13

2.  Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study.

Authors:  Shohei Kawachi; Keisaku Fujimoto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-05-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.